Brevan Howard Capital Management LP Procept Bio Robotics Corp Transaction History
Brevan Howard Capital Management LP
- $13.9 Billion
- Q4 2024
A detailed history of Brevan Howard Capital Management LP transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 28,849 shares of PRCT stock, worth $1.86 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
28,849
Previous 6,755
327.08%
Holding current value
$1.86 Million
Previous $541,000
329.21%
% of portfolio
0.02%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PRCT
# of Institutions
295Shares Held
41.6MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$331 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$224 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$113 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$95.9 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$77.7 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.87B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...